In the tumor micro-environment of several cancers, a subset of TIE2-expressing tumor associated macrophages has been described, with proangiogenic activity and negative prognostic value (52), implicating the interplay between tumor associated macrophages and angiogenesis as a possible therapeutic target (53). This evidence concerns the gene TEK and cancer.